Indeed, as recently demonstrated in a mouse model using tumors resistant to PD-L1 checkpoint blockade immunotherapy, high dose radiation directly upon the tumor mass induces a systemic increase of IFN-β levels and restores therapeutic efficacy by up-regulating MHC-I molecules in the tumor cells. Here, CD274 is linked to neoplasm.